Skip to main content
. 2021 Aug 25;10(6):517–522. doi: 10.1159/000517716

Fig. 1.

Fig. 1

Clinical and biochemical evolution of patient 1 (a). Clinical and biochemical evolution of patient 2 (b). MTC, medullary thyroid cancer; PR, partial response; CR, complete response. *The target lesion was a liver metastasis.